Gabriel Mantovani Bottós is a venture investor who co-founded Vesper Ventures. See contact routes.
Gabriel Mantovani Bottós is a venture investor who co-founded Vesper Ventures, a Brazil-based venture builder focused exclusively on deep biotech startups in human health, agro-environmental biotech, and bioenergy. He invests in early-stage companies, with initial checks ranging from US$150,000 to US$1.5 million per startup, targeting solutions for diseases without cures and sustainable food production. Notable portfolio companies include Aptah Biosciences (cancer and Alzheimer treatments), Vyro Biotherapeutics (zika virus-based cancer therapy), and Inedita Bio (genetic plant editing for pest resistance). His distinctive thesis treats science as the primary asset, acting as a “copilot” that co-creates businesses with scientists rather than functioning as a traditional VC or accelerator.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Florianópolis.
Investors like Gabriel Mantovani Bottós · Full investor directory · Investor access · Company funding database